These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting. Maurer M; Longhurst HJ; Fabien V; Li HH; Lumry WR Allergy Asthma Proc; 2014; 35(5):377-81. PubMed ID: 25198193 [TBL] [Abstract][Full Text] [Related]
14. Icatibant for the treatment of hereditary angioedema. Cole SW; Lundquist LM Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729 [TBL] [Abstract][Full Text] [Related]
18. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3. Lumry WR; Farkas H; Moldovan D; Toubi E; Baptista J; Craig T; Riedl M Int Arch Allergy Immunol; 2015; 168(1):44-55. PubMed ID: 26556097 [TBL] [Abstract][Full Text] [Related]